The inactivation of key tumor suppressor genes by mutation or deletion (e.g., TP53, ATM, CDKN2A, KMT2D) contributes to a genomic instability that facilitates the acquisition of secondary mutations that can drive lymphoma evolution in a Darwinian fashion [49,50]. This evidence concerns the gene TP53 and lymphoma.